150 related articles for article (PubMed ID: 33063195)
1. Obinutuzumab use complicated by progressive multifocal leukoencephalopathy in a patient with chronic lymphocytic leukemia: a case report.
Turine G; London F
Acta Neurol Belg; 2021 Jun; 121(3):781-783. PubMed ID: 33063195
[No Abstract] [Full Text] [Related]
2. Progressive multifocal leukoencephalopathy developing after obinutuzumab treatment for chronic lymphocytic leukemia.
Pejsa V; Lucijanic M; Jonjic Z; Prka Z; Vukorepa G
Ann Hematol; 2019 Jun; 98(6):1509-1510. PubMed ID: 30421169
[No Abstract] [Full Text] [Related]
3. Progressive Multifocal Leukoencephalopathy Following Treatment With Obinutuzumab in a Patient With Non-Hodgkin Follicular Lymphoma: A Case Report.
Diavati S; Asimakopoulos JV; Galopoulos D; Konstantinou I; Argyrakos T; Toulas P; Vassilakopoulos TP; Konstantopoulos K; Angelopoulou MK
Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):e601-e605. PubMed ID: 33814337
[No Abstract] [Full Text] [Related]
4. Rapid cognitive decline in a patient with chronic lymphocytic leukaemia: a case report.
Forryan J; Yong J
J Med Case Rep; 2020 Mar; 14(1):39. PubMed ID: 32127027
[TBL] [Abstract][Full Text] [Related]
5. Progressive multifocal leukoencephalopathy in a patient with chronic lymphocytic leukaemia treated with alemtuzumab.
Isidoro L; Pires P; Rito L; Cordeiro G
BMJ Case Rep; 2014 Jan; 2014():. PubMed ID: 24403383
[TBL] [Abstract][Full Text] [Related]
6. Ibrutinib Use Complicated by Progressive Multifocal Leukoencephalopathy.
Hsiehchen D; Arasaratnam R; Raj K; Froehlich T; Anderson L
Oncology; 2018; 95(5):319-322. PubMed ID: 30045034
[TBL] [Abstract][Full Text] [Related]
7. Sweet-Like Eruption Associated With Obinutuzumab Therapy for Chronic Lymphocytic Leukemia.
Korman AM; Hastings JG; Byrd JC; Kaffenberger BH
JAMA Dermatol; 2017 Jan; 153(1):108-110. PubMed ID: 27892987
[No Abstract] [Full Text] [Related]
8. Therapeutic Experience of Progressive Multifocal Leukoencephalopathy Development during Ofatumumab Therapy for Chronic Lymphocytic Leukemia.
Hashimoto Y; Tashiro T; Ogawa R; Nakamichi K; Saijo M; Tateishi T
Intern Med; 2021 Dec; 60(24):3991-3993. PubMed ID: 34176829
[TBL] [Abstract][Full Text] [Related]
9. Obinutuzumab monotherapy in previously untreated chronic lymphocytic leukemia.
Gay ND; Kozin E; Okada C; Danilov AV; Spurgeon S
Leuk Lymphoma; 2018 Sep; 59(9):2258-2260. PubMed ID: 29249186
[No Abstract] [Full Text] [Related]
10. A Chronic Lymphocytic Leukemia Patient with Progressive Multifocal Leukoencephalopathy Caused by John Cunningham Virus.
Ramadhani P; Bramantono B; Sedana MP
Acta Med Indones; 2018 Apr; 50(2):151-158. PubMed ID: 29950535
[TBL] [Abstract][Full Text] [Related]
11. Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab.
Freeman CL; Dixon M; Houghton R; Kreuzer KA; Fingerle-Rowson G; Herling M; Humphrey K; Böttcher S; de Costa CS; Iglesias V; Stilgenbauer S; Gribben J; Hallek M; Goede V
Leukemia; 2016 Aug; 30(8):1763-6. PubMed ID: 26979130
[No Abstract] [Full Text] [Related]
12. Progressive multifocal leukoencephalopathy as the presenting feature of chronic lymphocytic leukaemia.
Bruce DR; Rane NS; Schuh A
Br J Haematol; 2014 Nov; 167(4):570-1. PubMed ID: 24995592
[No Abstract] [Full Text] [Related]
13. Brain Lesion in the Setting of Chronic Rituximab Treatment.
Yazdani M; Antonucci M; Spampinato MV
JAMA Oncol; 2020 Jul; 6(7):1093-1094. PubMed ID: 32463440
[No Abstract] [Full Text] [Related]
14. [Multifocal progressive leukoencephalitis in a patient given fludarabine for chronic lymphoid leukemia].
Léonard S; Hulin C; Anxionnat R; Grignon Y; Taillandier L; Vespignani H
Rev Neurol (Paris); 2002 Nov; 158(11):1121-3. PubMed ID: 12451348
[TBL] [Abstract][Full Text] [Related]
15. Venetoclax and obinutuzumab for frontline treatment of chronic lymphocytic leukemia.
Stephens DM
Blood; 2019 Nov; 134(20):1691-1696. PubMed ID: 31488409
[TBL] [Abstract][Full Text] [Related]
16. Invasive fungal infections after obinutuzumab monotherapy for refractory chronic lymphocytic leukemia.
Tse E; Leung RY; Kwong YL
Ann Hematol; 2015 Jan; 94(1):165-7. PubMed ID: 24879095
[No Abstract] [Full Text] [Related]
17. [Progressive multifocal leukoencephalopathy: a complication in chronic B-cell lymphatic leukaemia].
van Kernebeek CR; Ünal E; Schaar CG; Bienfait HP
Ned Tijdschr Geneeskd; 2020 Mar; 164():. PubMed ID: 32267644
[TBL] [Abstract][Full Text] [Related]
18. Progressive Multifocal Leukoencephalopathy Among Ibrutinib Treatment In Chronic Lymphocytic Leukemia.
Çetintepe T; Gediz F; Akyar I; Çetintepe L; Koç AM
J Oncol Pharm Pract; 2022 Jul; 28(5):1249-1253. PubMed ID: 35037793
[TBL] [Abstract][Full Text] [Related]
19. Purging with chlorambucil to prevent infusion-related reaction before obinutuzumab administration: A monocentric pilot experience.
Autore F; Fresa A; Innocenti I; Tomasso A; Morelli F; Corbingi A; Sorà F; Laurenti L
Hematol Oncol; 2019 Dec; 37(5):641-643. PubMed ID: 31604368
[No Abstract] [Full Text] [Related]
20. Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab.
Martinot M; Ahle G; Petrosyan I; Martinez C; Gorun DM; Mohseni-Zadeh M; Fafi-Kremer S; Tebacher-Alt M
Emerg Infect Dis; 2018 Aug; 24(8):1594-1596. PubMed ID: 30016251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
